The Volkswagen Scandal: A New Beginning for the Automotive Industry?

Volkswagen AG; market cap (as of 25/09/15): €55.0bn   Small Software, Big Turmoil Volkswagen, the second largest carmaker in the world, headquartered in Wolfsburg, Germany, is in the middle of one of the largest automotive scandals to date. The company was discovered cheating on the emission tests by installing software Read more…

The new behemoth in the semiconductor industry: Avago to buy Broadcom

Avago Technologies Limited (AVGO): market cap (as of 25/09/2015): $34.2bn. Broadcom Corp. (BRCM): market cap (as of 25/09/2015): $31.4bn. Introduction Following a wave of consolidation in the semiconductor industry, which culminated last March with the NPX/Freescale $11.8bn deal, on May 27, Avago Technologies Limited and Broadcom Corporation announced that they have entered Read more…

“Wanna Play Big: Scale Up!” – Starwood Waypoint Residential Trust to Acquire Colony American Homes

Starwood Waypoint Residential Trust; market cap (as of 26/09/2015): $953.73m Colony American Homes; market cap (as of 26/09/2015): N.A. Introduction On September 21 Starwood Waypoint Residential Trust (NYSE: SWAY) and Colony American Homes (CAH), two of the largest U.S. single-family home landlords, agreed on the merger in an all-stock deal Read more…

WTI, S&P 500 and EURUSD: a difficult relationship

After weeks of firm bull sentiment, major equity markets (especially European ones) have experienced a fast correction that, although small compared to the incredible year-to-date performance, has started to disturb the overall view of investors. Such a movement has coincided with a rebound on the EUR/USD, which postponed the breakout Read more…

Want a robust quality drug pipeline? – Pay super premium!: Alexion to acquire Synageva in an $8.4bn deal

Alexion Pharmaceuticals Inc.; market cap (as of 09/05/2015): $32.54bn Synageva Biopharma Corp.; market cap (as of 09/05/2015): $7.91bn   Introduction On May 6, 2015, Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), the manufacturer of the world’s single most expensive prescription drug Soliris, and Synageva BioPharma Corp. (NASDAQ:GEVA) have entered into a definitive agreement Read more…

Is time up for Universal Banks? Deutsche Bank – Postbank case

Introduction As the financial system stabilises after the recent crisis, three distinct business models are emerging. First, focused retail institutions with a specific offering of products and services, such as American regional banks and Europe’s savings banks. Second, investment banks which also operate asset management businesses and private equity investments. Read more…